Harrow, Inc. is experiencing explosive growth, driven by its success in branded pharmaceuticals, especially Vevye. Vevye, HROW's flagship dry eye drug, is projected to reach $100M in 2025 and $300M in ...

I am writing this from my desk in St. Lucia with my girlfriend patiently waiting, so I will be brief. HROW reported earnings and lowered 2025 guidance to $270M to $280M from $280M+. This is utterly ...

The Primary Healthcare Commission announced the Community Drug Formulary (CDF) mechanism and promulgated the Guidelines of Practice for Community Pharmacy today. The move establishes a clear framework ...

In an age of constant communication, receiving phone calls or messages from unknown numbers has become increasingly common. Whether it's a missed call from an unfamiliar number, a potential scam or a ...

I don't know about you, but I'm tired of seeing AI used in place of actual search results in my web browser or used to summarize whatever I'm looking for. Google has become useless because of this, ...

England will have a single national formulary (SNF) for prescribing within the next two years under proposals outlined in the NHS 10-Year Plan. Backed by NICE, the SNF will reduce duplication and the ...

Serve You Rx, a pharmacy benefit manager, has added two recently approved biosimilars to Stelara to its formulary, the company announced Thursday. Milwaukee, Wisconsin-based Serve You Rx is an ...

When 22-year-old Cole Schmidtknecht tried to get a refill on the inhaler prescribed by his doctor to prevent asthma attacks, the medication that had formerly cost him less than $70 at his Appleton, ...

The TruePeopleSearch.com website works with both landline and cellphone numbers. It allows you to do a reverse phone lookup for any type of phone number, whether it's a cellphone or a landline. It's ...

The transition to the Trump-Vance administration is in full swing. Although the specifics of the new administration’s health agenda aren’t clear, some of the first—and most consequential—decisions the ...

Chennai-based Omexa Formulary Pvt Ltd plans to set up a new manufacturing unit for monoclonal antibodies and formulation products with an investment of ₹95 crore near Tindivanam, about 130 km South of ...